|
|
||||||||







*
AIDS Immunopathogenesis Unit, Department of Biology and Technology, and
Laboratory of Clinical Immunology, Division of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy;
IRIS Research Center, Chiron SpA, Siena, Italy; and
Picower Institute for Medical Research, Manhasset, NY 11030
We have recently shown that the binding subunit of pertussis toxin
(PTX-B) inhibits the entry and replication of macrophage-tropic (R5)
HIV-1 strains in activated primary T lymphocytes. Furthermore, PTX-B
suppressed the replication of T cell-tropic (X4) viruses at a postentry
level in the same cells. In this study we demonstrate that PTX-B
profoundly impairs entry and replication of the HIV-1ADA
(R5), as well as of HIV pseudotyped with either murine leukemia virus
or vesicular stomatitis virus envelopes, in primary monocyte-derived
macrophages. In addition, PTX-B strongly inhibited X4 HIV-1 replication
in U937 promonocytic cells and virus expression in the U937-derived
chronically infected U1 cell line stimulated with cytokines such as
TNF-
and IL-6. Of interest, TNF-
-mediated activation of the
cellular transcription factor NF-
B was unaffected by PTX-B.
Therefore, PTX-B may represent a novel and potent inhibitor of HIV-1
replication to be tested for efficacy in infected individuals. In
support of this proposition, a genetically modified mutant of PTX
(PT-9K/129G), which is safely administered for prevention of
Bordetella pertussis infection, showed an
in vitro anti-HIV profile superimposable to that of
PTX-B.
This article has been cited by other articles:
![]() |
O. D. Schneider, A. A. Weiss, and W. E. Miller Pertussis Toxin Signals through the TCR to Initiate Cross-Desensitization of the Chemokine Receptor CXCR4 J. Immunol., May 1, 2009; 182(9): 5730 - 5739. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Elia, E. Cassol, N. Sidenius, F. Blasi, A. Castagna, G. Poli, and M. Alfano Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion J. Leukoc. Biol., November 1, 2007; 82(5): 1212 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rizzi, M. P. Crippa, R. E. Jeeninga, B. Berkhout, F. Blasi, G. Poli, and M. Alfano Pertussis Toxin B-Oligomer Suppresses IL-6 Induced HIV-1 and Chemokine Expression in Chronically Infected U1 Cells via Inhibition of Activator Protein 1 J. Immunol., January 15, 2006; 176(2): 999 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Zocchi, P. Contini, M. Alfano, and A. Poggi Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-{beta} Production by NK Cells and TGF-{beta}-Mediated NK Cell Apoptosis J. Immunol., May 15, 2005; 174(10): 6054 - 6061. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lapenta, M. Spada, S. M. Santini, S. Racca, F. Dorigatti, G. Poli, F. Belardelli, and M. Alfano Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice Int. Immunol., April 1, 2005; 17(4): 469 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Su, P. B. Silver, P. Wang, C.-C. Chan, and R. R. Caspi Dissociating the Enhancing and Inhibitory Effects of Pertussis Toxin on Autoimmune Disease J. Immunol., September 1, 2003; 171(5): 2314 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alfano, N. Sidenius, B. Panzeri, F. Blasi, and G. Poli Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication PNAS, June 25, 2002; 99(13): 8862 - 8867. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |